HeartBeam

HeartBeam

Cardiology & Cardiovascular Health

About HeartBeam

HeartBeam, Inc. has developed the first portable, cable-free ECG system capable of synthesizing a 12-lead ECG for the assessment of arrhythmias. The company's flagship product, the HeartBeam AIMIGo, is a credit card-sized device that captures the heart's electrical signals from three dimensions and synthesizes them into a 12-lead ECG using a personalized transformation matrix. Unlike traditional 12-lead ECGs that require healthcare professionals and are impractical for at-home use, HeartBeam's system enables patients to capture symptoms wherever they are, providing clinical-grade data that clinicians trust. The device uses 5 electrodes to record 3-lead (in three-directions) electrocardiogram data, which is then transmitted to the HeartBeam cloud where on-call physicians can review recordings and follow up with patients. The technology was created by Dr. Branislav Vajdic, co-inventor of flash memory, in collaboration with a Harvard-Beth Israel cardiologist and two nuclear physicists. HeartBeam's approach delivers exceptional data fidelity through a patient-friendly system that simplifies access to actionable synthesized 12-lead ECG results, especially upon symptom onset when minutes matter. The company is leveraging artificial intelligence to analyze data-rich signals with plans to improve diagnostic accuracy, track cardiac trends over time, and detect subtle changes that could signal early warning signs. The technology is protected by over 20 issued patents and serves as a platform technology with broad applications including extended wear patches, watches, continuous monitoring systems, and deep learning solutions.

Mission & Story

Founding Story

The concept for HeartBeam's technology was created by Dr. Branislav Vajdic, the co-inventor of flash memory, in collaboration with a Harvard-Beth Israel cardiologist and two nuclear physicists.

Clinical Focus

Medical conditions and clinical areas addressed by HeartBeam.

ArrhythmiasSinus arrhythmiaSinus tachycardiaSinus bradycardiaAtrial premature complexesAtrial fibrillationVentricular premature complexAtrial flutterCoronary occlusionsMyocardial infarction (in development)

Who It Serves

PatientsPhysiciansHealthcare facilities

Milestones & Awards

Recent Milestones

FDA clearance for HeartBeam System 3-lead ECG recorder and 12-lead synthesis software. Positive AI results presented at EHRA. Published study in JACC: Advances demonstrating equivalence to standard 12-lead ECG.

Awards & Recognition

Award-winning, world-class team mentioned

Key Partnerships

Harvard-Beth Israel (technology development collaboration)

Company Details

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing
Last updated Jun 30, 2026

Similar Companies in this Market

View all 64
AccurKardia

AccurKardia

AI-powered platform for cardiovascular disease detection and cardiac risk assessment.

Acorai

Acorai

AI platform for cardiovascular disease detection and cardiac risk assessment.

Aisap

Aisap

11-50 employees

AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.

AliveCor

AliveCor

AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.

Anumana AI

Anumana AI

series c · 175 employees

Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.

Artrya

Artrya

11-50 employees

Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.

Bay Labs

Bay Labs

Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.

BunkerHill Health

BunkerHill Health

Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.